CopyMark Law Group
4.9
Drawing for WITLEAF

USPTO serial 90120722

WITLEAF

Reviewed by CopyMark Law Group

Reg. 6556548Status 700Renewal
Filing date
Status date
Registration date
Nov 9, 2021
Examiner
MARTIN, LIEF ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WITLEAF?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Assistance with this Renewal
Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Goods and services

ClassDescriptionStatusFirst use
010Electrocardiographs; Sphygmomanometers; Anaesthetic apparatus; Apparatus for artificial respiration; Heart pacemakers; Medical devices, namely, pulse oximeters; Surgical instruments and apparatus; Thermometers for medical purposes; Ultrasonic medical diagnostic apparatus; Vacuum pumps for medical purposesACTIVEJun 23, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Nov 9, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 5, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 4, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 23, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 23, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 13, 2021IUAFUSE AMENDMENT FILED—
Sep 13, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 16, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 19, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 30, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 15, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Dec 15, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 15, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 15, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 14, 2020DOCKASSIGNED TO EXAMINER—
Sep 19, 2020MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 18, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 21, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance